Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11986526
APP PUB NO 20210030877A1
SERIAL NO

17073618

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include low-molecular-weight and/or high-molecular-weight proteins, such as mAbs, and viscosity-reducing ionic liquids.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EAGLE BIOLOGICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crane, Alan Waban, US 16 100
Klibanov, Alexander M Boston, US 54 1924
Langer, Robert S Newton, US 624 35645
Larson, Alyssa M Dana Point, US 12 74
Love, Kevin Boston, US 19 131
Weight, Alisha K Mill Creek, US 12 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 21, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 21, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 21, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00